Enhancing bowel screening: Preventing colorectal cancer by flexible sigmoidoscopy in New Zealand.

摘要: Abstract Objectives The prevention of colorectal cancer (CRC) attainable from introducing once-in-a-lifetime flexible sigmoidoscopy (FSIG) screening was assessed. Study design This is a review relevant available information for the assessment impact and resource demands FSIG in New Zealand. Methods reduction bowel incidence achievable by one-off 50 to 59 years age, an age group which not currently offered, reviewed. CRC offer at 55 Zealand also estimated. number cost procedures required referrals colonoscopies savings treatment were calculated. Results Annually, about 27,500 would be if 50% those turning accepted screening. result three–four-fold fewer people being referred colonoscopy than national 2-yearly faecal immunochemical test (FIT) programme subsequently reduce demand false-positive FIT. cases prevented increase over 17 more 300 per year 2033. After 10–15 screening, annual health service costs, primarily prevented, sufficient completely fund Conclusions Inclusion significantly both mortality Zealand, current long-term costs.